(Last updated : 2020-05-12 12:11:21)
  岡脇 誠
   Department     ,
   Position  
■ BooK
1. 2011/03   Adoptive Immunotherapy of Cancer Using Autologous Lymphocytes, Cancer Growth and Progression 
■ Journal
1. 2016/05 A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells - An Analysis for Patients with Incurable Pancreatic Cancer. 
2. 2015/09 Current Cancer Immunotherapy Using Activated Lymphocytes -Do Lymphocytes Actually Recognize Cancer Cells? 
3. 2014/11 Imatinib Plasma Levels during Successful Long-Term Treatment of Metastatic Gastrointestinal Stromal Tumors 
4. 2014/06 Adoptive immunotherapy using autologous lymphocytes activated ex vivo with antigen stimulation for patients with incurable cancer 
5. 2011/07 A case of stroke due to tumor emboli associated with metastatic cardiac liposarcoma 
Display all(10)
■ Presentation
1. 2019/07/05 Poor prognosis of hypermutant colorectal cancer with KRAS mutations: A retrospective analysis of 1,052 Japanese colorectal cancer patients without treatment of immuno-checkpoint inhibitors   Link
2. 2019/04/01 Comparing effects of small molecular weight compounds on proliferation and chemotaxis of pancreatic cancer cells   Link
3. 2018/11/24 Efficacy of Ramucirumab in combination with second-line or salvage-line FOLFIRI in patients with metastatic colorectal cancer.  
4. 2018/11/10 Clinico-pathological features of hypermutant colorectal cancers analyzed over 1000 colorectal cancer  
5. 2018/10/22 Heat shock protein 90 (HSP90) inhibitor as a candidate treatment option for gastrointestinal stromal tumor with acquired resistance for conventional receptor tyrosine kinase inhibitors  
Display all(22)